CombiMatrix Introduces DNA Synthesizer For Microarrays

Newport Beach, CA - Acacia Research Corporation announced recently that its CombiMatrix group has launched the first CustomArray(TM) DNA Synthesizer, enabling researchers to build microarrays in their own facilities. For the first time, Pharmaceutical and Academic Core Facilities will have the ability to manufacture high quality commercial grade microarrays to their exact specifications with complete control over customization. This new system will allow researchers to fulfill their existing microarray requirements in addition to taking microarrays to new frontiers by exploring unique and novel applications.

"One of the biggest advantages of the CustomArray(TM) DNA Synthesizer, is the ability to fabricate commercial high quality arrays while having control over content and supply," said Michael Tognotti, Vice President of Sales and Marketing of CombiMatrix. "We have already shipped several machines and they are in use by customers at leading research organizations. We are very excited about this product and the large market it will serve."

The platform consists of the DNA CustomArray Synthesizer instrument and freely programmable microarrays or CustomArrays. Initially, the instrument has been designed to fabricate CombiMatrix's CustomArray12K (12,000 unique sites). The synthesizer will initially be marketed to the pharmaceutical, biotechnology, diagnostic, academic, and government sectors.

SOURCE: Acacia Research Corporation